Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014639

Director sold 10,000 shares at $25.65 ($256,518)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Welgus Howard G. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form 10b5-1 −10,000 $25.65 $256,518 49,744 D
Open-market sales · 10,000 sh · avg $25.65 · $256,518
Loading xslF345X05/wk-form4_1772658986.xml…